Participants in this study who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest ...

Statin use in patients with chronic liver disease was associated with a reduced risk of hepatocellular carcinoma (HCC) and hepatic decompensation, researchers found. In a cohort of 16,501 individuals ...

Participants in this study who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest outcomes for liver cancer, and participants with longer exposure to statins ...

Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...

Discover how statin use in chronic liver disease lowers liver cancer and decompensation risks, with added benefits from ...